183 related articles for article (PubMed ID: 473447)
21. Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test?
Chow NH; Tzai TS; Cheng HL; Chan SH; Lin JS
Urol Int; 1994; 53(1):18-23. PubMed ID: 7974880
[TBL] [Abstract][Full Text] [Related]
22. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology: A Correlative Study of 124 Cases.
Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F
Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983
[TBL] [Abstract][Full Text] [Related]
23. [Usefulness of Fluorescent Urine Cytology in the Diagnosis of Urothelial Carcinoma].
Yamamichi G; Nakata W; Yoshimura A; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M
Hinyokika Kiyo; 2020 Nov; 66(11):377-381. PubMed ID: 33271653
[TBL] [Abstract][Full Text] [Related]
24. Use of ThinPrep monolayer technique and cytospin preparation in urine cytology: a comparative analysis.
Nassar H; Ali-Fehmi R; Madan S
Diagn Cytopathol; 2003 Mar; 28(3):115-8. PubMed ID: 12619090
[TBL] [Abstract][Full Text] [Related]
25. Reliability of urinary cytodiagnosis in urothelial neoplasms.
Shenoy UA; Colby TV; Schumann GB
Cancer; 1985 Oct; 56(8):2041-5. PubMed ID: 4027934
[TBL] [Abstract][Full Text] [Related]
26. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
27. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
28. [The Paris System, 2022 edition: What is new?].
Courtade-Saïdi M
Ann Pathol; 2024 May; 44(3):188-194. PubMed ID: 38242741
[TBL] [Abstract][Full Text] [Related]
29. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
30. [The value of urinary cytology in the diagnosis of high grade urothelial tumors].
Niedworok C; Rembrink V; Hakenberg OW; Börgermann C; Rossi R; Schneider T; Becker M; Szarvas T; von Ostau C; Swoboda A; Rübben H; vom Dorp F
Urologe A; 2009 Sep; 48(9):1018, 1020-2, 1024. PubMed ID: 19697005
[TBL] [Abstract][Full Text] [Related]
31. [A new terminology for urinary cytopathology: The Paris System for Reporting Urinary Cytology (2015)].
Courtade-Saïdi M; Cochand-Priollet B; Vielh P; Piaton E;
Ann Pathol; 2019 Sep; 39(5):344-351. PubMed ID: 31255415
[TBL] [Abstract][Full Text] [Related]
32. [How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre].
Ulldemolins Aznar P; Muñoz Vicente E; Roselló-Sastre E
Rev Esp Patol; 2022; 55(2):125-134. PubMed ID: 35483768
[TBL] [Abstract][Full Text] [Related]
33. [Urine-based cytological diagnosis against the background of the new histopathological classification].
Tschirdewahn S; Boergermann C; Becker M; Szarvas T; Rübben H; vom Dorp F
Urologe A; 2009 Jun; 48(6):615-8. PubMed ID: 19557466
[TBL] [Abstract][Full Text] [Related]
34. Grading of upper urinary tract transitional cell carcinoma by computed DNA content and p53 expression.
Minimo C; Tawfiek ER; Bagley DH; McCue PA; Bibbo M
Urology; 1997 Dec; 50(6):869-74. PubMed ID: 9426716
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract.
Guelstein VI; Tchipysheva TA; Ermilova VD; Troyanovsky SM
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(1):1-5. PubMed ID: 7691361
[TBL] [Abstract][Full Text] [Related]
36. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
[TBL] [Abstract][Full Text] [Related]
37. Clinical and cytopathological factors affecting the cellularity of urinary cell blocks and the implication for diagnosis and follow-up of urinary bladder urothelial carcinoma.
Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M
Cytopathology; 2018 Dec; 29(6):537-544. PubMed ID: 29873845
[TBL] [Abstract][Full Text] [Related]
38. The clinical value of urinary cytology: 12 years of experience with 615 patients.
Maier U; Simak R; Neuhold N
J Clin Pathol; 1995 Apr; 48(4):314-7. PubMed ID: 7615848
[TBL] [Abstract][Full Text] [Related]
39. Urinary cytology changes in protease inhibitor induced urolithiasis.
Hamm M; Wawroschek F; Rathert P
J Urol; 2000 Apr; 163(4):1249-50. PubMed ID: 10737512
[No Abstract] [Full Text] [Related]
40. [The Paris system for classification of urinary cytology].
Savic S; Vlajnic T; Bubendorf L
Pathologe; 2017 Sep; 38(5):451-462. PubMed ID: 28791453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
